NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.2
(-0.38%)
CNY 5.2
(-0.38%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 3.31 Billion CNY | -10.07% |
| 2022 | 3.25 Billion CNY | 10.96% |
| 2021 | 2.93 Billion CNY | 16.04% |
| 2020 | 2.53 Billion CNY | 3.03% |
| 2019 | 2.45 Billion CNY | 18.81% |
| 2018 | 2.06 Billion CNY | 18.92% |
| 2017 | 1.73 Billion CNY | 10.65% |
| 2016 | 1.57 Billion CNY | 6.98% |
| 2015 | 1.46 Billion CNY | 9.81% |
| 2014 | 1.33 Billion CNY | 12.01% |
| 2013 | 1.19 Billion CNY | -12.4% |
| 2012 | 1.36 Billion CNY | 12.75% |
| 2011 | 1.2 Billion CNY | 11.01% |
| 2010 | 1.08 Billion CNY | 19.11% |
| 2009 | 914.51 Million CNY | 9.91% |
| 2008 | 832.08 Million CNY | 20.81% |
| 2007 | 688.74 Million CNY | 44.11% |
| 2006 | 477.93 Million CNY | 5.74% |
| 2005 | 451.96 Million CNY | 5.22% |
| 2004 | 429.54 Million CNY | 2.54% |
| 2003 | 418.9 Million CNY | 58.89% |
| 2002 | 263.63 Million CNY | 14.4% |
| 2001 | 230.44 Million CNY | 5.15% |
| 2000 | 219.16 Million CNY | 17.29% |
| 1999 | 186.84 Million CNY | 13.59% |
| 1998 | 164.48 Million CNY | 33.98% |
| 1997 | 122.76 Million CNY | 35.47% |
| 1996 | 90.62 Million CNY | 7.87% |
| 1995 | 84.01 Million CNY | 24.8% |
| 1994 | 67.31 Million CNY | 11.82% |
| 1993 | 60.2 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 815.25 Million CNY | 9.2% |
| 2024 Q2 | 838.54 Million CNY | 2.86% |
| 2024 Q3 | 813.86 Million CNY | 0.7% |
| 2023 Q2 | 823.1 Million CNY | 1.14% |
| 2023 Q4 | 746.59 Million CNY | -9.67% |
| 2023 FY | 2.93 Billion CNY | -10.07% |
| 2023 Q1 | 813.78 Million CNY | -9.5% |
| 2023 Q3 | 826.5 Million CNY | 0.41% |
| 2022 Q1 | 728.8 Million CNY | -6.77% |
| 2022 Q2 | 826.95 Million CNY | 13.47% |
| 2022 Q3 | 804.14 Million CNY | -2.76% |
| 2022 Q4 | 899.22 Million CNY | 11.82% |
| 2022 FY | 3.25 Billion CNY | 10.96% |
| 2021 Q1 | 654.53 Million CNY | 3.12% |
| 2021 FY | 2.93 Billion CNY | 16.04% |
| 2021 Q2 | 732.91 Million CNY | 11.98% |
| 2021 Q3 | 768.04 Million CNY | 4.79% |
| 2021 Q4 | 781.7 Million CNY | 1.78% |
| 2020 Q4 | 634.72 Million CNY | -11.71% |
| 2020 FY | 2.53 Billion CNY | 3.03% |
| 2020 Q1 | 524.6 Million CNY | -20.26% |
| 2020 Q2 | 652.95 Million CNY | 24.47% |
| 2020 Q3 | 718.92 Million CNY | 10.1% |
| 2019 Q1 | 554.72 Million CNY | -11.25% |
| 2019 Q3 | 618.15 Million CNY | -1.26% |
| 2019 FY | 2.45 Billion CNY | 18.81% |
| 2019 Q4 | 657.89 Million CNY | 6.43% |
| 2019 Q2 | 626.05 Million CNY | 12.86% |
| 2018 Q2 | 490.77 Million CNY | 2.63% |
| 2018 Q3 | 473.9 Million CNY | -3.44% |
| 2018 FY | 2.06 Billion CNY | 18.92% |
| 2018 Q4 | 625.06 Million CNY | 31.9% |
| 2018 Q1 | 478.18 Million CNY | 6.8% |
| 2017 Q3 | 447.5 Million CNY | 1.36% |
| 2017 Q1 | 402.15 Million CNY | -4.71% |
| 2017 Q4 | 447.75 Million CNY | 0.05% |
| 2017 Q2 | 441.5 Million CNY | 9.78% |
| 2017 FY | 1.73 Billion CNY | 10.65% |
| 2016 Q3 | 389.59 Million CNY | 0.85% |
| 2016 Q1 | 373.54 Million CNY | -3.81% |
| 2016 FY | 1.57 Billion CNY | 6.98% |
| 2016 Q4 | 422.03 Million CNY | 8.33% |
| 2016 Q2 | 386.31 Million CNY | 3.42% |
| 2015 FY | 1.46 Billion CNY | 9.81% |
| 2015 Q2 | 352.93 Million CNY | -2.11% |
| 2015 Q4 | 388.32 Million CNY | 5.77% |
| 2015 Q3 | 367.15 Million CNY | 4.03% |
| 2015 Q1 | 360.55 Million CNY | 7.12% |
| 2014 Q3 | 348.02 Million CNY | 4.03% |
| 2014 Q4 | 336.59 Million CNY | -3.28% |
| 2014 FY | 1.33 Billion CNY | 12.01% |
| 2014 Q1 | 318.59 Million CNY | 0.78% |
| 2014 Q2 | 334.53 Million CNY | 5.0% |
| 2013 Q4 | 316.12 Million CNY | 3.48% |
| 2013 Q1 | 283.55 Million CNY | -34.21% |
| 2013 FY | 1.19 Billion CNY | -12.4% |
| 2013 Q3 | 305.49 Million CNY | 5.67% |
| 2013 Q2 | 289.1 Million CNY | 1.96% |
| 2012 Q1 | 285.72 Million CNY | -0.79% |
| 2012 Q2 | 318.31 Million CNY | 11.41% |
| 2012 Q3 | 328.32 Million CNY | 3.14% |
| 2012 Q4 | 431.01 Million CNY | 31.28% |
| 2012 FY | 1.36 Billion CNY | 12.75% |
| 2011 Q4 | 288 Million CNY | -9.84% |
| 2011 Q2 | 302.94 Million CNY | 1.39% |
| 2011 Q1 | 298.79 Million CNY | 0.63% |
| 2011 FY | 1.2 Billion CNY | 11.01% |
| 2011 Q3 | 319.42 Million CNY | 5.44% |
| 2010 Q2 | 272.05 Million CNY | 7.26% |
| 2010 Q1 | 253.63 Million CNY | 0.37% |
| 2010 Q4 | 296.92 Million CNY | 11.34% |
| 2010 FY | 1.08 Billion CNY | 19.11% |
| 2010 Q3 | 266.67 Million CNY | -1.98% |
| 2009 Q3 | 216.45 Million CNY | -8.97% |
| 2009 FY | 914.51 Million CNY | 9.91% |
| 2009 Q4 | 252.69 Million CNY | 16.74% |
| 2009 Q1 | 207.57 Million CNY | -1.98% |
| 2009 Q2 | 237.78 Million CNY | 14.55% |
| 2008 Q2 | 227.58 Million CNY | 18.83% |
| 2008 FY | 832.08 Million CNY | 20.81% |
| 2008 Q4 | 211.77 Million CNY | 5.26% |
| 2008 Q3 | 201.19 Million CNY | -11.6% |
| 2008 Q1 | 191.52 Million CNY | -4.25% |
| 2007 Q4 | 200.02 Million CNY | 15.77% |
| 2007 Q1 | 140.76 Million CNY | 15.06% |
| 2007 FY | 688.74 Million CNY | 44.11% |
| 2007 Q2 | 175.17 Million CNY | 24.45% |
| 2007 Q3 | 172.78 Million CNY | -1.36% |
| 2006 Q1 | 117.24 Million CNY | -3.66% |
| 2006 FY | 477.93 Million CNY | 5.74% |
| 2006 Q4 | 122.33 Million CNY | 5.42% |
| 2006 Q3 | 116.04 Million CNY | -5.13% |
| 2006 Q2 | 122.31 Million CNY | 4.33% |
| 2005 Q4 | 121.69 Million CNY | 8.03% |
| 2005 Q1 | 107.23 Million CNY | -14.98% |
| 2005 Q2 | 110.39 Million CNY | 2.94% |
| 2005 Q3 | 112.64 Million CNY | 2.04% |
| 2005 FY | 451.96 Million CNY | 5.22% |
| 2004 Q2 | 105.72 Million CNY | 10.77% |
| 2004 FY | 429.54 Million CNY | 2.54% |
| 2004 Q1 | 95.44 Million CNY | -15.9% |
| 2004 Q3 | 102.23 Million CNY | -3.29% |
| 2004 Q4 | 126.13 Million CNY | 23.38% |
| 2003 FY | 418.9 Million CNY | 58.89% |
| 2003 Q4 | 113.49 Million CNY | 10.43% |
| 2003 Q1 | 77.58 Million CNY | 37.63% |
| 2003 Q2 | 125.05 Million CNY | 61.17% |
| 2003 Q3 | 102.77 Million CNY | -17.82% |
| 2002 Q3 | 72.25 Million CNY | 2.73% |
| 2002 FY | 263.63 Million CNY | 14.4% |
| 2002 Q1 | 64.67 Million CNY | 0.0% |
| 2002 Q2 | 70.33 Million CNY | 8.75% |
| 2002 Q4 | 56.37 Million CNY | -21.98% |
| 2001 FY | 230.44 Million CNY | 5.15% |
| 2000 FY | 219.16 Million CNY | 17.29% |
| 1999 FY | 186.84 Million CNY | 13.59% |
| 1998 FY | 164.48 Million CNY | 33.98% |
| 1997 FY | 122.76 Million CNY | 35.47% |
| 1996 FY | 90.62 Million CNY | 7.87% |
| 1995 FY | 84.01 Million CNY | 24.8% |
| 1994 FY | 67.31 Million CNY | 11.82% |
| 1993 FY | 60.2 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 19.29 Billion CNY | 82.828% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 4.59 Billion CNY | 27.958% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.89 Billion CNY | 14.985% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.13 Billion CNY | -190.941% |
| Aurora Optoelectronics Co.,Ltd. | -319.56 Million CNY | 1136.811% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 23.41 Million CNY | -14051.53% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 936.59 Million CNY | -253.76% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 2.45 Billion CNY | -34.997% |